<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial" dtd-version="1.1" specific-use="sps-1.9" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">6ZLrw7kGythsMQ9dnTYQ4rJ</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2019000900417</article-id>
      <article-id pub-id-type="doi">10.5935/abc.20190208</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Short Editorial</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Aspects of Non-Pharmacological Treatment in Peripheral Arterial Disease</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0003-4877-3304</contrib-id>
          <name>
            <surname>Alves</surname>
            <given-names>Maria Janieire de N. Nunes</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Souza</surname>
            <given-names>Francis Ribeiro de</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <aff id="aff1">
          <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
          <institution content-type="orgdiv1">Faculdade de Medicina</institution>
          <institution content-type="orgdiv2">Hospital das Clinicas</institution>
          <addr-line>
            <city>S&#227;o Paulo</city>
            <state>SP</state>
          </addr-line>
          <country country="BR">Brazil</country>
          <institution content-type="original">Instituto do Cora&#231;&#227;o (InCor), Hospital das Clinicas da Faculdade de Medicina da Universidade de S&#227;o Paulo (HC-FMUSP), S&#227;o Paulo, SP - Brazil</institution>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1"><bold>Mailing Address: Maria Janieire de N. Nunes Alves,</bold> Av. Dr. En&#233;as de Carvalho Aguiar, 44 Jardim Am&#233;rica - S&#227;o Paulo, SP - Brazil. E-mail: <email>janieire.ja@gmail.com</email>
				</corresp>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic">
        <day>10</day>
        <month>10</month>
        <year>2019</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <month>09</month>
        <year>2019</year>
      </pub-date>
      <volume>113</volume>
      <issue>3</issue>
      <fpage>417</fpage>
      <lpage>418</lpage>
      <permissions>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Peripheral Arterial Disease/physiopathology</kwd>
        <kwd>Peripheral Arterial Disease/drug therapy</kwd>
        <kwd>Aged</kwd>
        <kwd>Intermittent Claudication</kwd>
        <kwd>Ankle Brachial Index</kwd>
        <kwd>Exercise</kwd>
        <kwd>Prevention and Control</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Peripheral arterial disease (PAD) is one of the main atherosclerotic diseases in the elderly population<xref ref-type="bibr" rid="B1">1</xref> which limits the performance of physical activity. Patients with PAD who have intermittent claudication may have gait impairment, which compromises daily living activities.<xref ref-type="bibr" rid="B2">2</xref> In addition, these patients have other comorbidities that may increase cardiovascular risk.<xref ref-type="bibr" rid="B1">1</xref><sup>,</sup><xref ref-type="bibr" rid="B3">3</xref> Regular exercise is a non-drug treatment recommended for the prevention and treatment of cardiovascular disease. On the other hand, maintaining adherence to a physical training program becomes a major challenge.</p>
    <p>The present study<xref ref-type="bibr" rid="B4">4</xref> exposes the physical activity pattern of patients with PAD and demonstrates the high rate of a sedentary lifestyle with aging. In fact, the disease itself leads to physical limitation, which in turn is also a worsening factor of the disease, since the recommendation of vigorous physical activity has therapeutic effects that contribute, in addition to the chronic use of arterial vasodilator drugs. In addition, chronic arterial vasodilation due to the use of medications may lead to reduced long-term peripheral flow, as arterial vasodilation promoted by medication further reduces perfusion pressure in the lower limb peripheral muscles and intensifies the low level of physical activity in patients with PAD, according to current physical activity recommendations.</p>
    <p>The assessment of the degree of physical activity was performed by a device over a period of 7 days, and the data are relevant in classifying the degree of physical limitation with aging, as well as, demonstrating the significance of sedentary lifestyle, may corroborate to further aggravate the disease and cardiovascular risk. On the other hand, the device does not evaluate or quantify localized muscular resistance training (strength), which may underestimate the results pointed out by the study.</p>
    <p>Clearly, the importance of developing strategies for these patients to engage in regular exercise. The main reason for these patients with PAD not progressing with physical training is pain related to increased muscle energy demand, called intermittent claudication, especially in the calf region during walking.<xref ref-type="bibr" rid="B5">5</xref> Moderate to vigorous exercise can precipitate the symptoms of intermittent claudication and this becomes a barrier for these patients to engage in physical activity. Thus, low intensity and progressive aerobic exercise can be used as a strategy to delay these symptoms. In addition, patients with intermittent claudication have muscle atrophy, and reduced muscle strength and endurance in the lower limbs increase the fragility of these patients, especially with aging.<xref ref-type="bibr" rid="B6">6</xref> In this aspect, strength exercises and peripheral muscular endurance (bodybuilding) should be used.</p>
    <p>Although the literature recommends exercises with aerobic characteristics, such as walking, as the main exercise modality for these patients with PAD, muscle overload exercises have also been recommended as part of a physical exercise program in this population.<xref ref-type="bibr" rid="B7">7</xref><sup>,</sup><xref ref-type="bibr" rid="B8">8</xref>
		</p>
    <p>Regular exercise should be used as a non-pharmacological tool for the treatment and prevention of cardiovascular disease in patients with PAD and intermittent claudication, so it is important to develop a specific exercise program, especially to delay the onset of symptoms. intermittent claudication, because, besides preventing the onset of pain and the interruption of exercise, it can be a motivational factor that will imply the adherence of these patients to physical activity.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="other">
        <p>Short Editorial related to the article: Physical Activity Levels in Peripheral Artery Disease Patients</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1</label>
        <mixed-citation>1 Wang J, Zhou S, Bronks R, Graham J, Myers S. Effects of supervised treadmill-walking training on strength and endurance of the calf muscles of individuals with peripheral arterial disease. Clin J Sport Med. 2006;16(5):397-400.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bronks</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Graham</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Myers</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Effects of supervised treadmill-walking training on strength and endurance of the calf muscles of individuals with peripheral arterial disease</article-title>
          <source>Clin J Sport Med</source>
          <year>2006</year>
          <volume>16</volume>
          <issue>5</issue>
          <fpage>397</fpage>
          <lpage>400</lpage>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation>2 Regensteiner JG1, Steiner JF, Hiatt WR. Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg. 1996;23(1):104-15.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Regensteiner</surname>
              <given-names>JG1</given-names>
            </name>
            <name>
              <surname>Steiner</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Hiatt</surname>
              <given-names>WR</given-names>
            </name>
          </person-group>
          <article-title>Exercise training improves functional status in patients with peripheral arterial disease</article-title>
          <source>J Vasc Surg</source>
          <year>1996</year>
          <volume>23</volume>
          <issue>1</issue>
          <fpage>104</fpage>
          <lpage>115</lpage>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation>3 Fowkes FG1, Rudan D, Rudan I. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet.2013; 19;382(9901):1329-40.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fowkes</surname>
              <given-names>FG1</given-names>
            </name>
            <name>
              <surname>Rudan</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rudan</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis</article-title>
          <source>Lancet</source>
          <year>2013</year>
          <volume>19</volume>
          <issue>382(9901)</issue>
          <fpage>1329</fpage>
          <lpage>1340</lpage>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation>4 Gerage AM, Correia Ma, Oliveira PML, Palmeira AC, Domingues JR, Zeratti AE, et al. N&#237;veis de atividade f&#237;sica em pacientes com doen&#231;a arterial perif&#233;rica. Arq Bras Cardiol. 2019; 113(3):410-416.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gerage</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Correia</surname>
              <given-names>Ma</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>PML</given-names>
            </name>
            <name>
              <surname>Palmeira</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Domingues</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Zeratti</surname>
              <given-names>AE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>N&#237;veis de atividade f&#237;sica em pacientes com doen&#231;a arterial perif&#233;rica</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2019</year>
          <volume>113</volume>
          <issue>3</issue>
          <fpage>410</fpage>
          <lpage>416</lpage>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation>5 Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000; 31(1 Pt 2):S1-S296.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dormandy</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Rutherford</surname>
              <given-names>RB</given-names>
            </name>
          </person-group>
          <article-title>Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC)</article-title>
          <source>J Vasc Surg</source>
          <year>2000</year>
          <volume>31</volume>
          <issue>1</issue>
          <issue-part>Pt 2</issue-part>
          <fpage>S1</fpage>
          <lpage>S296</lpage>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation>6 Regensteiner JG1, Wolfel EE, Brass EP, Carry MR, Ringel SP, Hargarten ME,et al. Chronic changes in skeletal muscle histology and function in peripheral arterial disease. Circulation.1993;87(2):413-21.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Regensteiner</surname>
              <given-names>JG1</given-names>
            </name>
            <name>
              <surname>Wolfel</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Brass</surname>
              <given-names>EP</given-names>
            </name>
            <name>
              <surname>Carry</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Ringel</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Hargarten</surname>
              <given-names>ME</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Chronic changes in skeletal muscle histology and function in peripheral arterial disease</article-title>
          <source>Circulation</source>
          <year>1993</year>
          <volume>87</volume>
          <issue>2</issue>
          <fpage>413</fpage>
          <lpage>421</lpage>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation>7 Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. American Association for Vascular Surgery; Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease; American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation.2006; 113(11):e463-654.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirsch</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Haskal</surname>
              <given-names>ZJ</given-names>
            </name>
            <name>
              <surname>Hertzer</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Bakal</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Creager</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Halperin</surname>
              <given-names>JL</given-names>
            </name>
            <etal/>
            <collab>American Association for Vascular Surgery</collab>
            <collab>Society for Vascular Surgery</collab>
            <collab>Society for Cardiovascular Angiography and Interventions</collab>
            <collab>Society for Vascular Medicine and Biology</collab>
            <collab>Society of Interventional Radiology</collab>
            <collab>ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease</collab>
            <collab>American Association of Cardiovascular and Pulmonary Rehabilitation</collab>
            <collab>National Heart, Lung, and Blood Institute</collab>
            <collab>Society for Vascular Nursing</collab>
            <collab>TransAtlantic Inter-Society Consensus</collab>
            <collab>Vascular Disease Foundation</collab>
          </person-group>
          <article-title>ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation</article-title>
          <source>Circulation</source>
          <year>2006</year>
          <volume>113</volume>
          <issue>11</issue>
          <fpage>e463</fpage>
          <lpage>e654</lpage>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <mixed-citation>8 Hiatt WR1, Wolfel EE, Meier RH, Regensteiner JG. Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response. Circulation.1994;90(4):1866-74.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hiatt</surname>
              <given-names>WR1</given-names>
            </name>
            <name>
              <surname>Wolfel</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Meier</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Regensteiner</surname>
              <given-names>JG</given-names>
            </name>
          </person-group>
          <article-title>Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease: Implications for the mechanism of the training response</article-title>
          <source>Circulation</source>
          <year>1994</year>
          <volume>90</volume>
          <issue>4</issue>
          <fpage>1866</fpage>
          <lpage>1874</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="s1" xml:lang="pt">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Minieditorial</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Aspectos do Tratamento n&#227;o Farmacol&#243;gico em Doen&#231;a Arterial Perif&#233;rica</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0003-4877-3304</contrib-id>
          <name>
            <surname>Alves</surname>
            <given-names>Maria Janieire de N. Nunes</given-names>
          </name>
          <xref ref-type="aff" rid="aff2"/>
          <xref ref-type="corresp" rid="c2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Souza</surname>
            <given-names>Francis Ribeiro de</given-names>
          </name>
          <xref ref-type="aff" rid="aff2"/>
        </contrib>
        <aff id="aff2">
          <institution content-type="original">Instituto do Cora&#231;&#227;o (InCor), Hospital das Clinicas da Faculdade de Medicina da Universidade de S&#227;o Paulo (HC-FMUSP), S&#227;o Paulo, SP - Brasil</institution>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="c2"><bold>Correspond&#234;ncia: Maria Janieire de N. Nunes Alves,</bold> Av. Dr. En&#233;as de Carvalho Aguiar, 44 Jardim Am&#233;rica - S&#227;o Paulo, SP - Brasil. E-mail: <email>janieire.ja@gmail.com</email>
				</corresp>
      </author-notes>
      <kwd-group xml:lang="pt">
        <title>Palavras-chave</title>
        <kwd>Doen&#231;a Arterial Perif&#233;rica/fisiopatologia</kwd>
        <kwd>Doen&#231;a Arterial Perif&#233;rica/drug theray</kwd>
        <kwd>Idoso</kwd>
        <kwd>Claudica&#231;&#227;o Intermitente</kwd>
        <kwd>&#205;ndice Tornozelo-Bra&#231;o</kwd>
        <kwd>Exerc&#237;cio</kwd>
        <kwd>Preven&#231;&#227;o e Controle</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>A doen&#231;a arterial perif&#233;rica (DAP) &#233; uma das principais doen&#231;as ateroscler&#243;ticas na popula&#231;&#227;o idosa<xref ref-type="bibr" rid="B1">1</xref> que limita &#224; realiza&#231;&#227;o de atividade f&#237;sica. Pacientes com DAP que apresentam claudica&#231;&#227;o intermitente podem apresentar um comprometimento da marcha, que compromete as atividades da vida di&#225;ria.<xref ref-type="bibr" rid="B2">2</xref> Al&#233;m disso, esses pacientes apresentam outras comorbidades que podem aumentar o risco cardiovascular.<xref ref-type="bibr" rid="B1">1</xref><sup>,</sup><xref ref-type="bibr" rid="B3">3</xref> A pr&#225;tica regular de exerc&#237;cio f&#237;sico &#233; um tratamento n&#227;o medicamentoso recomendado para preven&#231;&#227;o e tratamento de doen&#231;as cardiovasculares. Por outro lado, manter a ades&#227;o a um programa de treinamento f&#237;sico se torna um grande desafio.</p>
      <p>O estudo em quest&#227;o,<xref ref-type="bibr" rid="B4">4</xref> exp&#245;e o padr&#227;o de atividade f&#237;sica de pacientes com DAP, e demonstra a alta taxa de sedentarismo com o envelhecimento. De fato, a pr&#243;pria doen&#231;a leva a limita&#231;&#227;o f&#237;sica, o que por sua vez &#233; tamb&#233;m, um fator de piora da doen&#231;a, haja vista que a recomenda&#231;&#227;o de atividade f&#237;sica vigorosa tem efeitos terap&#234;uticos que contribuem, adicionalmente ao uso cr&#244;nico de drogas vasodilatadoras arteriais. Al&#233;m disso, a vasodilata&#231;&#227;o arterial cr&#244;nica decorrente do uso de medicamentos, pode trazer redu&#231;&#227;o do fluxo perif&#233;rico &#224; longo prazo, uma vez que a vasodilata&#231;&#227;o arterial promovida pela medica&#231;&#227;o reduz, ainda mais, a press&#227;o de perfus&#227;o na musculatura perif&#233;rica de membros inferiores e, que intensifica o baixo n&#237;vel de atividade f&#237;sica em pacientes com DAP, de acordo com recomenda&#231;&#245;es atuais de atividade f&#237;sica.</p>
      <p>A avalia&#231;&#227;o do grau de atividade f&#237;sica foi realizada por um dispositivo, durante um per&#237;odo de 7 dias, e os dados s&#227;o relevantes em classificar o grau de limita&#231;&#227;o f&#237;sica com o avan&#231;ar da idade, bem como, demonstraram tamb&#233;m, a signific&#226;ncia do sedentarismo, que pode corroborar para agravar ainda mais a doen&#231;a e o risco cardiovascular. Por outro lado, o dispositivo n&#227;o avalia ou quantifica o treinamento da resist&#234;ncia muscular localizada (for&#231;a), o que pode subestimar os resultados apontados pelo estudo.</p>
      <p>&#201; clara, a import&#226;ncia de se elaborar estrat&#233;gias para que esses pacientes se engajem na pr&#225;tica regular de exerc&#237;cio f&#237;sico. O principal motivo desses pacientes com DAP n&#227;o progredirem com o treinamento f&#237;sico &#233; a dor relacionada ao aumento da demanda energ&#233;tica do m&#250;sculo, denominada, claudica&#231;&#227;o intermitente, principalmente na regi&#227;o da panturrilha durante a caminhada.<xref ref-type="bibr" rid="B5">5</xref> Exerc&#237;cios f&#237;sicos de moderada &#224; vigorosa intensidade podem precipitar os sintomas da claudica&#231;&#227;o intermitente e isso se torna uma barreira para que esses pacientes se envolvam em atividades f&#237;sicas. Dessa maneira, os exerc&#237;cios aer&#243;bicos de baixa intensidade e de forma progressiva, podem ser utilizados como estrat&#233;gia para retardar esses sintomas. Al&#233;m disso, pacientes com claudica&#231;&#227;o intermitente apresentam atrofia muscular e a redu&#231;&#227;o da for&#231;a e resist&#234;ncia muscular nos membros inferiores aumenta a fragilidade desses doentes, principalmente com o avan&#231;ar da idade.<xref ref-type="bibr" rid="B6">6</xref> Nesse aspecto, exerc&#237;cios de for&#231;a e resist&#234;ncia muscular perif&#233;rica (muscula&#231;&#227;o) deveriam ser utilizados.</p>
      <p>Embora a literatura recomende exerc&#237;cios com caracter&#237;sticas aer&#243;bicas, como a caminhada, como principal modalidade de exerc&#237;cio para esses pacientes com DAP, exerc&#237;cios de sobrecarga muscular, tamb&#233;m tem sido recomendado como parte de um programa de exerc&#237;cio f&#237;sico nessa popula&#231;&#227;o.<xref ref-type="bibr" rid="B7">7</xref><sup>,</sup><xref ref-type="bibr" rid="B8">8</xref>
			</p>
      <p>A pr&#225;tica regular de exerc&#237;cio f&#237;sico deve ser utilizada como ferramenta n&#227;o farmacol&#243;gica para o tratamento e preven&#231;&#227;o das doen&#231;as cardiovasculares em pacientes com DAP e claudica&#231;&#227;o intermitente, portanto &#233; importante se elaborar um programa de exerc&#237;cios f&#237;sicos espec&#237;ficos, principalmente com intuito de retardar o aparecimento dos sintomas de claudica&#231;&#227;o intermitente, pois, al&#233;m de prevenir o desencadeamento de dor, a interrup&#231;&#227;o do exerc&#237;cio, pode ser um fator motivacional que implicar&#225; na ader&#234;ncia desses pacientes &#224; pr&#225;tica de atividade f&#237;sica.</p>
    </body>
    <back>
      <fn-group>
        <fn fn-type="other">
          <p>Minieditorial referente ao artigo: N&#237;veis de Atividade F&#237;sica Em Pacientes Com Doen&#231;a Arterial Perif&#233;rica</p>
        </fn>
      </fn-group>
    </back>
  </sub-article>
</article>
